Page last updated: 2024-11-02

oxybutynin and Leukemia, Myeloid, Acute

oxybutynin has been researched along with Leukemia, Myeloid, Acute in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zama, D1
Masetti, R1
Vendemini, F1
Di Donato, F1
Morelli, A1
Prete, A1
Pession, A1
Han, X1
Li, H1
Zhou, D1
Chen, Z1
Gu, Z1

Other Studies

2 other studies available for oxybutynin and Leukemia, Myeloid, Acute

ArticleYear
Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients.
    Pediatric transplantation, 2013, Volume: 17, Issue:1

    Topics: Child; Cystitis; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Hyperbaric Oxy

2013
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Accounts of chemical research, 2020, 11-17, Volume: 53, Issue:11

    Topics: Animals; Antibodies, Monoclonal; B7-H1 Antigen; Disease Models, Animal; Drug Delivery Systems; Extra

2020